Probiotics, Nutrition and Gut Microbiome

Sep 18-19, 2020


New York, United States of America

!!! LexisConferences Welcomes you !!!

We take immense pleasure in inviting you all to the Probiotics, Nutrition and Gut Microbiome” which is scheduled in the month of SEPTEMBER 18-19, 2020 at NEW YORK, USA organized by LexisConferences Pvt Ltd in collaboration with generous support and cooperation from enthusiastic academicians and Editorial Board Members focusing on specialist areas in Probiotics & Gut Health.

The main theme of the conference is “Advanced Research on Probiotics, Nutrition and Gut Health” a perfect amalgamation of intellectually stimulating synchronized Scientific Sessions, Interactive Workshops, Comprehensive Networking opportunities, Future Innovations & Many more.

The 2 Day’s program is currently evolving through collaboration between local and international experts and is expected to be very innovative.

We look forward to seeing you in Newyork!!

Best Regards,
Honourable Organizing Committee
LexisConferences Pvt Ltd | Belgium

Market Analysis Probiotics:

The probiotics market is estimated at USD 49.4 Billion in 2018 and projected to grow at a CAGR of 7.0%, to reach USD 69.3 billion by 2023. The ecumenical probiotics market is segmented by Type Aliment and Beverage (Dairy Products, Fermented Products, Non-Potations, Dietary Supplements and others), Dietary Supplement, and Animal Victual; Distribution Channel (Supermarkets/ Hypermarkets, Pharmacies/Health Stores, Accomodation Stores, and Other Distribution Channels), and Geography. The magnification of the market is driven by factors such as health benefits associated with probiotic-fortified foods and technological advancements in probiotic products. Key drivers for the market’s magnification are the incrementing utilization of high alimental content in foods due to incrementing consumer vigilance about salubrious diets. One of the major restraints in the magnification of the market is the international quality standards, regulations for probiotic products, and the high R&D costs for developing incipient Probiotic Strains.


Note: **The official language of the Conference is English. There will be no simultaneous translation**

Michael Charles Murphy
Saffron Wellness Ltd, UK

Alexander Sulakvelidze
Intralytix, Inc, USA

Pascal A Ronfard
Groupe Solactis SAS, France

Sreenivasa R J
National Institute of Nutrition, India

Program Overview